As of 2025-12-29, the Relative Valuation of Cullinan Oncology Inc (CGEM) is (90.28) USD. This relative valuation is based on P/E multiples. With the latest stock price at 10.37 USD, the upside of Cullinan Oncology Inc based on Relative Valuation is -970.6%.
The range of the Relative Valuation is (81.03) - (91.75) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 22.0x - 25.0x | 24.6x |
| Forward P/E multiples | 22.1x - 29.4x | 24.6x |
| Fair Price | (81.03) - (91.75) | (90.28) |
| Upside | -881.4% - -984.7% | -970.6% |
| Date | P/E |
| 2025-12-24 | -2.80 |
| 2025-12-23 | -2.72 |
| 2025-12-22 | -2.82 |
| 2025-12-19 | -2.64 |
| 2025-12-18 | -2.72 |
| 2025-12-17 | -2.61 |
| 2025-12-16 | -2.78 |
| 2025-12-15 | -2.95 |
| 2025-12-12 | -3.25 |
| 2025-12-11 | -3.37 |
| 2025-12-10 | -3.40 |
| 2025-12-09 | -3.37 |
| 2025-12-08 | -3.39 |
| 2025-12-05 | -2.89 |
| 2025-12-04 | -2.88 |
| 2025-12-03 | -2.86 |
| 2025-12-02 | -2.78 |
| 2025-12-01 | -2.93 |
| 2025-11-28 | -3.10 |
| 2025-11-26 | -3.20 |
| 2025-11-25 | -3.21 |
| 2025-11-24 | -3.52 |
| 2025-11-21 | -2.58 |
| 2025-11-20 | -2.38 |
| 2025-11-19 | -2.30 |
| 2025-11-18 | -2.33 |
| 2025-11-17 | -2.39 |
| 2025-11-14 | -2.33 |
| 2025-11-13 | -2.25 |
| 2025-11-12 | -2.28 |
| 2025-11-11 | -2.13 |
| 2025-11-10 | -2.03 |
| 2025-11-07 | -1.96 |
| 2025-11-06 | -2.00 |
| 2025-11-05 | -1.99 |
| 2025-11-04 | -2.02 |
| 2025-11-03 | -2.13 |
| 2025-10-31 | -2.36 |
| 2025-10-30 | -2.06 |
| 2025-10-29 | -2.10 |
| 2025-10-28 | -2.31 |
| 2025-10-27 | -2.20 |
| 2025-10-24 | -2.11 |
| 2025-10-23 | -2.11 |
| 2025-10-22 | -2.21 |
| 2025-10-21 | -2.31 |
| 2025-10-20 | -2.33 |
| 2025-10-17 | -2.14 |
| 2025-10-16 | -2.38 |
| 2025-10-15 | -2.35 |